These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27315562)

  • 81. The QIP: will it improve dialysis care? An overview.
    Fishbane S; Miller I; Danko H; Masani N
    Nephrol News Issues; 2012 Jan; 26(1):20, 22-4, 26. PubMed ID: 22359961
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Medicare Program; End-Stage Renal Disease Prospective Payment System, and Quality Incentive Program. Final Rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2015 Nov; 80(215):68967-9077. PubMed ID: 26552112
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Bundled-rate legislation for Medicare reimbursement for dialysis services: implications for anemia management with ESAs.
    Charytan C
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2355-62. PubMed ID: 21071515
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Looking for a good story...
    Coutts LR
    Nephrol News Issues; 1999 Apr; 13(4):67, 70. PubMed ID: 10418453
    [No Abstract]   [Full Text] [Related]  

  • 85. Medicare program; end-stage renal disease program; prospective reimbursement for dialysis services and approval of special purpose renal dialysis facilities--HCFA. Final rule.
    Fed Regist; 1983 May; 48(92):21254-91. PubMed ID: 10299129
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
    Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The Role of Big Data in the Development and Evaluation of US Dialysis Care.
    Erickson KF; Qureshi S; Winkelmayer WC
    Am J Kidney Dis; 2018 Oct; 72(4):560-568. PubMed ID: 29921451
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Bundled Payment Reform and Dialysis Facility Closures in ESKD.
    Norouzi S; Zhao B; Awan A; Winkelmayer WC; Ho V; Erickson KF
    J Am Soc Nephrol; 2020 Mar; 31(3):579-590. PubMed ID: 32019784
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Coalition releases position statement on protecting home dialysis in bundled ESRD payment.
    Home Hemodialysis Workgroup
    Nephrol News Issues; 2009 Sep; 23(10):40, 43. PubMed ID: 19807003
    [No Abstract]   [Full Text] [Related]  

  • 90. Blood transfusion practices in dialysis patients in a dynamic regulatory environment.
    Hirth RA; Turenne MN; Wilk AS; Wheeler JR; Sleeman KK; Zhang W; Paul MA; Nahra TA; Messana JM
    Am J Kidney Dis; 2014 Oct; 64(4):616-21. PubMed ID: 24560166
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The changing tide in ESRD care.
    Sullivan JD
    Nephrol News Issues; 2010 Jul; 24(8):24, 27-8. PubMed ID: 20695319
    [No Abstract]   [Full Text] [Related]  

  • 92. Are cost pressures influencing the way nephrologists provide care?
    Dubman R
    Nephrol News Issues; 2014 Mar; 28(3):22, 24, 33. PubMed ID: 24720012
    [No Abstract]   [Full Text] [Related]  

  • 93. Alternative Payment Models and Opportunities to Address Disparities in Kidney Disease.
    Tummalapalli SL; Ibrahim SA
    Am J Kidney Dis; 2021 May; 77(5):769-772. PubMed ID: 33098924
    [No Abstract]   [Full Text] [Related]  

  • 94. Helping patients with end-stage renal disease.
    Kuchta K; VanBuskirk S; Houglum M
    Am J Nurs; 2007 May; 107(5):35-6. PubMed ID: 17443073
    [No Abstract]   [Full Text] [Related]  

  • 95. Medicare program; standards for quality of water used in dialysis and revised guidelines on reuse of hemodialysis filters for end-stage renal disease (ESRD) patients--HCFA. Final rule.
    Fed Regist; 1995 Sep; 60(180):48039-44. PubMed ID: 10151653
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: a comparison using US Renal Data System data.
    Krishnan M; Weinhandl ED; Jackson S; Gilbertson DT; Lacson E
    Am J Kidney Dis; 2015 Nov; 66(5):802-12. PubMed ID: 26015277
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval.
    Powe NR; Griffiths RI; de Lissovoy G; Anderson GF; Watson AJ; Greer JW; Herbert RJ; Eggers PW; Milam RA; Whelton PK
    JAMA; 1992 Sep; 268(11):1434-40. PubMed ID: 1512912
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Early winners and losers in dialysis center pay-for-performance.
    Saunders MR; Lee H; Chin MH
    BMC Health Serv Res; 2017 Dec; 17(1):816. PubMed ID: 29216894
    [TBL] [Abstract][Full Text] [Related]  

  • 99. ESRD program at the crossroads of health care reform.
    Neumann ME
    Nephrol News Issues; 1993 Oct; 7(10):5, 40. PubMed ID: 8232632
    [No Abstract]   [Full Text] [Related]  

  • 100. Major declines in epoetin dosing after prospective payment system based on dialysis facility organizational status.
    Thamer M; Zhang Y; Kaufman J; Kshirsagar O; Cotter D; Hernán MA
    Am J Nephrol; 2014; 40(6):554-60. PubMed ID: 25592645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.